FindTrial
Sign In

Effects of atorvastatin and genetic veriations in the treatment of chronic subdural hematoma.

Effects of atorvastatin and genetic veriations in the treatment of chronic subdural hematoma.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16010082
Enrollment
Unknown
Registered
2016-12-05
Start date
2016-12-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic subdural hematoma

Interventions

Treatment:Atorvastatin oral

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or female, aged 16-95 years; 2. The GCS score of 15; 3. CT or MR in the diagnosis of chronic subdural hematoma; 4. No indications of emergency operation; 5. No - pulmonary insufficiency, no liver and kidney dysfunction; 6. No atorvastatin taboo; 7. No clear contraindication.

Exclusion criteria

Exclusion criteria: 1. There is emergency surgery patients with syndrome of chronic subdural hematoma; 2. Pregnant women; 3. Taking atorvastatin contraindications; 4. There is existing drilling drainage for operation contraindication of chronic subdural hematoma patients; 5. Can not complete the follow-up of patients.

Design outcomes

Primary

MeasureTime frame
Volume changes of CSDH;—

Secondary

MeasureTime frame
Rate of operation;Cost;GOS;Rate of CSDH recurrence;—

Countries

China

Contacts

Public ContactZhiguang Pan

Huashan Hospital, Fudan University

15197533@qq.com+86 021 52887732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026